FibroGen is cutting 127 jobs at its San Francisco headquarters, roughly 75 percent of its U.S. workforce, after two late-stage…
Read More

FibroGen is cutting 127 jobs at its San Francisco headquarters, roughly 75 percent of its U.S. workforce, after two late-stage…
Read More
Youth Cancer Europe and Pagalbos onkologiniams ligoniams asociacija (POLA) participated in the EU Cancer Information Portal Project (EU-CiP) General Assembly…
Read More
GSK announced Tuesday it will acquire Nuvalent, a cancer drug developer, for $10.6 billion. CEO Luke Miels, six months into…
Read More